These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2385988)
21. [Macrophage transformation of mononuclear cells following primary and secondary experimental immunization with measles vaccine]. Zakharova TR; Bolotovskiĭ VM; Titova NS Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):72-4. PubMed ID: 2741608 [TBL] [Abstract][Full Text] [Related]
22. Reduced Antibody Response to Infant Measles Vaccination: Effects Based on Type and Timing of the First Vaccine Dose Persist After the Second Dose. Carazo Perez S; De Serres G; Bureau A; Skowronski DM Clin Infect Dis; 2017 Oct; 65(7):1094-1102. PubMed ID: 28595358 [TBL] [Abstract][Full Text] [Related]
23. [Induction of specific antibodies by measles vaccine. Study in normal and undernourished infants 6 to 24-months old]. Maluf EM; Ribeiro RC; Rodriguez MA; Skraba I; de Carvalho JF Rev Inst Med Trop Sao Paulo; 1985; 27(6):353-60. PubMed ID: 3939164 [No Abstract] [Full Text] [Related]
24. Measles immunization. Successes and failures. Yeager AS; Davis JH; Ross LA; Harvey B JAMA; 1977 Jan; 237(4):347-51. PubMed ID: 576165 [TBL] [Abstract][Full Text] [Related]
26. [The characteristics of the synthesis of specific antihemagglutinins and antihemolysins in subjects inoculated with live measles vaccine in different climatic and geographical areas]. Novitskiĭ IA; Tikhonova NT; Mamaeva TA; Dubov AV Zh Mikrobiol Epidemiol Immunobiol; 1994; (3):64-8. PubMed ID: 7941872 [TBL] [Abstract][Full Text] [Related]
27. [The strength of postvaccinal measles immunity in schoolchildren]. Smorodinova IP; Miroshnikova NK; Sobolevskaia AA Tr Inst Im Pastera; 1985; 62():46-50. PubMed ID: 2954275 [No Abstract] [Full Text] [Related]
28. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine]. Borcić B; Smerdel S; Abu Eldan J; Kolić J; Ferdebar M; Kordić D; Mohacek N Lijec Vjesn; 1989; 111(4-5):131-4. PubMed ID: 2770398 [TBL] [Abstract][Full Text] [Related]
29. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination. Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO Microbios; 1991; 67(274):33-6. PubMed ID: 1758308 [TBL] [Abstract][Full Text] [Related]
30. The antibody response to different measles virus antigens under various conditions of immunization. Norrby E; Salmi AA; Vandvik B; Hammarskjöld B; Panelius M Adv Exp Med Biol; 1972; 31(0):49-69. PubMed ID: 4212389 [No Abstract] [Full Text] [Related]
31. II. Primary and secondary immunological response of experimental animals to attenuated and nonattenuated measles virus. Aleksandrowicz J; Polna I; Sadowski W Acta Microbiol Pol A; 1973; 5(3):139-45. PubMed ID: 4203633 [No Abstract] [Full Text] [Related]
32. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era. Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581 [TBL] [Abstract][Full Text] [Related]
33. Optimum age for measles immunisation: study of pre- and post-immunization level of HI antibody titres. Bhatnagar SK; Mohan M; Kumar P; Balaya S; Prabhakar AK; Bhargava SK Indian Pediatr; 1981 Sep; 18(9):625-9. PubMed ID: 6797943 [No Abstract] [Full Text] [Related]
34. [The immune status of children in foci of measles infection studied by an immunoenzyme method]. Iuminova NV; Unanov SS; Krasnova VP; Malancheva OA; Kovaleva LG; Liashenko VA Zh Mikrobiol Epidemiol Immunobiol; 1990 Aug; (8):35-8. PubMed ID: 2239001 [TBL] [Abstract][Full Text] [Related]
35. Ineffectiveness of historical data in predicting measles susceptibility. Scott RM; Butler AB; Schydlower M; Rawlings P Pediatrics; 1984 Jun; 73(6):777-80. PubMed ID: 6728580 [TBL] [Abstract][Full Text] [Related]
36. [Measles epidemiology and the status of specific immunity in Novgorod Province during a mass immunization]. Golubeva LI; Brantseva IV Tr Inst Im Pastera; 1985; 62():68-72. PubMed ID: 2954277 [No Abstract] [Full Text] [Related]
37. Measles immunity in children vaccinated before one year of age. Schluederberg A; Lamm SH; Landrigan PJ; Black FL Am J Epidemiol; 1973 Jun; 97(6):402-9. PubMed ID: 4713935 [No Abstract] [Full Text] [Related]
38. A randomized trial demonstrating successful boosting responses following simultaneous aerosols of measles and rubella (MR) vaccines in school age children. Sepúlveda-Amor J; Valdespino-Gómez JL; García-García Mde L; Bennett J; Islas-Romero R; Echaniz-Aviles G; de Castro JF Vaccine; 2002 Jun; 20(21-22):2790-5. PubMed ID: 12034106 [TBL] [Abstract][Full Text] [Related]
39. Current chemotherapy protocols for childhood acute lymphoblastic leukemia induce loss of humoral immunity to viral vaccination antigens. Nilsson A; De Milito A; Engström P; Nordin M; Narita M; Grillner L; Chiodi F; Björk O Pediatrics; 2002 Jun; 109(6):e91. PubMed ID: 12042585 [TBL] [Abstract][Full Text] [Related]
40. [Use of the leukocyte adherence inhibition reaction for assessing the effectiveness of vaccination against measles]. Mikheeva IV; Plouéktova LE; Veksler KhM Zh Mikrobiol Epidemiol Immunobiol; 1989 Jan; (1):33-6. PubMed ID: 2469266 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]